Volta Labs Automates Twist’s Full Hybrid Capture Portfolio on Callisto
BOSTON, June 12, 2026 Volta Labs, a leader in genomics workflow automation, has announced the launch of Twist Bioscience’s...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BOSTON, June 12, 2026 Volta Labs, a leader in genomics workflow automation, has announced the launch of Twist Bioscience’s...
SALT LAKE CITY, Utah, June 8, 2026 Seek Labs announced a major milestone in antiviral research with the completion...
EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...
SOUTH SAN FRANCISCO, California, May 27, 2026 Human Longevity, Inc. (HLI) has announced the creation of Human Life Foundation...
SINGAPORE, May 28, 2026 Gene Solutions announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
SALT LAKE CITY, May 26, 2026 Myriad Genetics announced the launch of Prolaris® + AI, the first prostate cancer...
Austin, Texas, USA – May 21, 2026 Natera, Inc., a global leader in cell-free DNA testing and precision medicine,...
SAN DIEGO, Calif., May 19, 2026 Rancho BioSciences has officially launched OmicsHQâ„¢, a comprehensive and expertly curated multi-omics data...
SOUTH SAN FRANCISCO, Calif., May 2026 Mission Bio announced new data demonstrating the power of its Targeted Single-Cell DNA+RNA...
EMERYVILLE, CALIFORNIA, April 29, 2026 Profluent has announced a strategic multi-program research collaboration with Eli Lilly and Company to...
